Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
September 09 2020 - 8:30AM
Business Wire
Cerus Corporation (Nasdaq:CERS) announced today that William
‘Obi’ Greenman, Cerus’ president and chief executive officer, and
Kevin D. Green, Cerus’ chief financial officer, are scheduled to
participate in the following two conferences:
- The Cantor Fitzgerald Virtual Global Healthcare Conference on
Tuesday, September 15th at 2:00 P.M. ET.
- The H.C. Wainwright 22nd Annual Global Investment Conference on
Wednesday, September 16th at 12:00 P.M. ET.
A live webcast of the events will be available on the Investor
Relations page of the Cerus web site at http://www.cerus.com/ir. A
replay will be available for approximately two weeks following the
completion of the event.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the
world’s blood supply and aims to become the preeminent global blood
products company. Based in Concord, California, our employees are
dedicated to deploying and supplying vital technologies and
pathogen-protected blood components for blood centers, hospitals
and ultimately patients who rely on safe blood. With the INTERCEPT
Blood System, we are focused on protecting patients by delivering
the full complement of reliable products and expertise for
transfusion medicine. Cerus develops and markets the INTERCEPT
Blood System and remains the only company in the blood transfusion
space to earn both CE Mark and FDA approval for pathogen reduction
of both platelet and plasma components. Cerus currently markets and
sells the INTERCEPT Blood System in the United States, Europe, the
Commonwealth of Independent States, the Middle East and selected
countries in other regions around the world. The INTERCEPT Red
Blood Cell system is in clinical development. For more information
about Cerus, visit www.cerus.com and follow us on LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200909005424/en/
Tim Lee – Investor Relations Director Cerus Corporation
925-288-6137
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Sep 2023 to Sep 2024